Exos Asset Management’s Revelation Biosciences, Inc. Unit REVBU Stock Holding History

Exos Asset Management’s Portfolio REVBU Stock Details REVBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,117	Closed	-$271K	–	490
2020 Q4	$271K	Buy	+25,117	New	+$255K	0.44%	87

Other funds holding REVBU

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Exos Asset Management's REVBU Position: Q1 2021 in Review

Exos Asset Management sold out of Revelation Biosciences, Inc. Unit (REVBU) in Q1 2021, closing a stake of 25,117 shares — an estimated $271K sold.

Exos Asset Management first reported a position in REVBU in Q4 2020 and held it in 1 quarter. The position peaked at $271K in Q4 2020. 4 funds tracked by Wall St. Rank hold REVBU as of Q1 2021.

Exos Asset Management reported no remaining Revelation Biosciences, Inc. Unit position as of Q1 2021 after selling out during the quarter.
Exos Asset Management sold 25,117 Revelation Biosciences, Inc. Unit shares in Q1 2021, an estimated $271K.
Exos Asset Management first reported a position in Revelation Biosciences, Inc. Unit in Q4 2020 and held it in 1 quarter.
Exos Asset Management's Revelation Biosciences, Inc. Unit position peaked at $271K in Q4 2020.
4 funds tracked by Wall St. Rank held Revelation Biosciences, Inc. Unit as of Q1 2021.

Based on Exos Asset Management's 13F filing for Q1 2021, filed 5 May 2021.